Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsProfitability & Management Efficiency of Balaxi Pharmaceuticals Ltd. (BALAXI)
Valuation Ratio Profitability Ratio Solvency Ratio Efficiency Ratio
Profitability Ratios of Balaxi Pharmaceuticals Ltd.
| Year | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 12.35 | 1.81 | 30.78 | 48.29 | 68.23 | 31.98 | 69.29 | -49.52 | -32.14 | -2.21 | -0.0027 |
| ROE % | 10.82 | -1.19 | 25.13 | 42.12 | 58.69 | 22.00 | 55.84 | -49.52 | -7.49 | -2.55 | 3.17 |
| ROA % | 8.08 | -0.925 | 19.18 | 27.01 | 38.26 | 16.97 | 32.19 | -45.65 | -7.35 | -2.25 | 2.78 |
| ROIC % | 8.85 | -1.08 | 23.63 | 40.80 | 55.57 | 22.00 | 55.84 | -49.52 | 0 | 0 | 0 |
| Operating Margin % | 11.07 | 17.80 | 16.28 | 17.74 | 18.20 | 18.14 | 11.99 | 0 | 22.11 | -141.42 | 35.04 |
| Net Margin % | 8.57 | -0.991 | 13.66 | 17.06 | 16.49 | 13.38 | 14.46 | 0 | 28.35 | -163.58 | 82.71 |
| EBITDA Margin % | 11.45 | 2.40 | 17.59 | 19.75 | 19.30 | 19.46 | 17.97 | 0 | 21.65 | -332.04 | 1.27 |
| Asset Turnover % | 102.89 | 96.90 | 161.69 | 202.35 | 341.07 | 216.89 | 348.85 | 0 | -20.69 | 1.36 | 0 |
| Free cash flow To Revenue % | -20.13 | 0.734 | -2.65 | 2.43 | -1.10 | -31.22 | -11.12 | 0 | 23.11 | -78.27 | 168.30 |
| Dividend Payout Ratio % | 0 | 0 | 1.08 | 0 | 0 | 0 | 0 | 0 | 0 | -136.80 | 80.01 |
| Cash Flow TO Assets % | -11.28 | 1.89 | 2.53 | 19.35 | 0.0032 | -39.09 | -24.67 | -40.21 | -5.54 | -0.971 | 5.74 |
Compound Annual Growth Rate (CAGR) of Profitability Ratios of Balaxi Pharmaceuticals Ltd.
| Period | 1 Year | 3 Year | 5 Year | 7 Year | 10 Year |
|---|---|---|---|---|---|
| ROCE | 581.15 % | -36.52 % | -17.33 % | 12.28 % | 131.90 % |
| ROE | 1011.44 % | -36.43 % | -13.23 % | 12.06 % | 13.04 % |
| ROA | 973.19 % | -33.12 % | -13.79 % | 11.75 % | 11.25 % |
| ROIC | 917.22 % | -39.92 % | -16.65 % | 11.77 % | 0.00 |
| Operating Margin | -37.82 % | -14.54 % | -9.41 % | 0.00 | -10.89 % |
| Net Margin | 965.13 % | -20.51 % | -8.52 % | 0.00 | -20.29 % |
| EBITDA Margin | 376.22 % | -16.62 % | -10.07 % | 0.00 | 24.55 % |
| Asset Turnover | 6.18 % | -20.18 % | -13.86 % | 0.00 | 0.00 |
| Free cash flow To Revenue | -2843.32 % | -117.38 % | 8.40 % | 0.00 | -7.80 % |
| Dividend Payout Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow TO Assets | -698.26 % | -37.21 % | 22.01 % | 16.61 % | -14.77 % |
Formula of common Profitability Ratios
About TSR TECH Strength / Valuation / Growth
TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, Moving Avg, Chart Patterns, Candlestick and proprietary algorithms.Technical Strength is calculate from 1 Min Tick to One Month Tick.
TSR Growth analyses dozen of Historical , MRQ, TTM Parameters, Returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential.
TSR Value analyses dozen of Historical , MRQ, TTM Parameters, Returns of Individual Stocks vis-a-vis sector , broad based Index to access its value.
This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share.